Clinical Trials Logo

Acute Blood Loss Anemia clinical trials

View clinical trials related to Acute Blood Loss Anemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT02877381 Active, not recruiting - Clinical trials for Acute Blood Loss Anemia

Tranexamic Acid in Revision Total Joint Arthroplasty

Start date: April 2016
Phase: Phase 4
Study type: Interventional

To determine the optimal dosing regimen and route of administration of tranexamic acid (TXA) [single dose intravenous (IV), double dose intravenous, intravenous + topical, and oral repeated dosing] to minimize post-operative blood loss and transfusion requirements following revision total knee arthroplasty (RTKA).

NCT ID: NCT02762773 Recruiting - Pregnancy Clinical Trials

Effect of Non-Dissection of the Inferior Rectus Sheath on Intraoperative Blood Loss

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of non-dissecting the inferior rectus sheath during primary cesarean delivery on post-operative hemoglobin and post-operative pain control as measured by VAS score and opioid anesthesia use in the first 72 hours post-op.

NCT ID: NCT02138175 Withdrawn - Bleeding Clinical Trials

Continuous Hemoglobin Monitoring: Detection of Acute Blood Loss - Accurate, Timely and Cost-effective

Start date: January 2016
Phase: N/A
Study type: Observational

The purpose of the study is to determine whether noninvasive hemoglobin monitoring is sensitive and accurate enough to detect a significant downward trend in hemoglobin in patients at risk for significant bleeding. If this can be shown, it has the potential to spare patients multiple invasive blood draws as well as allow for earlier detection of significant blood loss and therefore positively impact on patient morbidity and mortality. Additionally, it may represent significant financial cost savings in that it may allow for patients to be monitored in a non-intensive care unit setting. This will be an observational study. The continuous hemoglobin monitor will be connected to the patient and hemoglobin measurement data will be collected. Routine laboratory hemoglobin monitoring will occur concurrently at a pre-specified frequency as well as at the physician's discretion based on usual clinical information. The physician will be blinded to the continuous hemoglobin monitoring readings and therefore patient care will not be affected by the use of the monitor. Once the study has ended, the data will then be analyzed to assess for correlation between continuous hemoglobin monitoring readings and laboratory hemoglobin measurement.

NCT ID: NCT01683955 Recruiting - Osteoarthritis, Hip Clinical Trials

Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty

Start date: January 2013
Phase: Phase 1
Study type: Interventional

This study aims to assess postoperative blood loss and transfusion rates in total hip replacement after one-time administration of topical tranexamic acid.

NCT ID: NCT01370460 Completed - Clinical trials for Osteoarthritis, Knee

Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty

Start date: June 2011
Phase: Phase 2
Study type: Interventional

This study aims to assess postoperative blood loss and transfusion rates in total knee replacement after one-time administration of topical tranexamic acid.